Promega Maxwell 16 System Now CE Marked for European Union
MADISON, WISCONSIN (May 29, 2008)
Promega Corporation announces the Maxwell 16 DNA purification system is now CE marked in accordance with the requirements of Directive 98/79/EC IVD. The new mark particularly helps European clinical laboratories performing tests in molecular pathology and transplant HLA to achieve compliance with IVD directives in their countries. The new Maxwell 16 System supports DNA-based tests performed on blood and buffy-coat by clinical labs, including sample preparation for human transplantation donor-matching tests done in HLA labs. The system already meets the General Purpose Medical Device requirements in the United States.
Currently, labs can face extreme pressure in delivering test results quickly enough to act on the transplant of an organ while it is still viable. Manual sample extraction methods require hands-on time of 40 minutes or more. With Maxwell 16, up to 16 DNA samples can be purified simultaneously, without user intervention, in about 30 minutes, with higher yield and more consistency than similar methods.
"Our intent is to support clinical labs in their life-saving work by offering a purification method that handles more samples faster and more accurately than existing manual methods," explains Andy Bertera, Promega Vice President of Marketing. "Medical Technologists in both in Europe and the United States need to have access to affordable automation that meets regulatory requirements and allows them to deliver test results as quickly as possible."
The Maxwell 16 System is:
- Optimized for DNA purification of blood or buffy-coat samples
- Consistent in delivering results with high yield and concentration
- Fully integrated with pre-filled cartridges and pre-programmed protocols
- Innovative with design that prevents cross contamination
- Compact - as a small bench top unit, it requires only as much space as an open lap-top computer
For more information on Maxwell, please visit www.maxwell-16.com.
*Image available upon request.
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company's 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.
These pages contain communications on Promega product releases and corporate activities. For additional new product information, see the new products page or the specific product or application area.
For more information about a new release article or about Promega in general, contact Penny Patterson at 1-608-274-4330 or complete this form.